(Q42247094)

19 October 2017

Positive direct antiglobulin tests and immune hemolytic anemia in patients receiving procainamide (English)

1 reference

19 October 2017

Positive Direct Antiglobulin Tests and Immune Hemolytic Anemia in Patients Receiving Procainamide (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM198409273111301

30 September 2023

1 reference

S. Kleinman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6332273

30 September 2023

R. Nelson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6332273

30 September 2023

L. Smith

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6332273

30 September 2023

D. Goldfinger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6332273

30 September 2023

language of work or name

English

0 references

publication date

1 September 1984

1 reference

19 October 2017

27 September 1984

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6332273

full work available at URL

30 September 2023

http://www.nejm.org/doi/pdf/10.1056/NEJM198409273111301

1 reference

https://api.crossref.org/works/10.1056/NEJM198409273111301

The New England Journal of Medicine

30 September 2023

published in

1 reference

19 October 2017

311

1 reference

19 October 2017

809-812

1 reference

19 October 2017

13

1 reference

Antinuclear antibody induced by procainamide. A prospective study

19 October 2017

1

1 reference

https://api.crossref.org/works/10.1056/NEJM198409273111301

Procainamide-induced lupus erythematosus. Clinical and laboratory observations

30 September 2023

2

1 reference

https://api.crossref.org/works/10.1056/NEJM198409273111301

Procainamide-induced serologic changes in asymptomatic patients

30 September 2023

3

1 reference

https://api.crossref.org/works/10.1056/NEJM198409273111301

Long-term use of procaine amide following acute myocardial infarction

30 September 2023

4

1 reference

https://api.crossref.org/works/10.1056/NEJM198409273111301

Lymphocyte alteration by procainamide: relation to drug-induced lupus erythematosus syndrome

30 September 2023

6

1 reference

https://api.crossref.org/works/10.1056/NEJM198409273111301

Hypocomplementemia in Procainamide-Associated Systemic Lupus Erythematosus

30 September 2023

8

1 reference

https://api.crossref.org/works/10.1056/NEJM198409273111301

A new method of antibody elution from red blood cells

30 September 2023

9

1 reference

https://api.crossref.org/works/10.1056/NEJM198409273111301

Journal of clinical and laboratory medicine

30 September 2023

10

70

800

Tan

1967

1 reference

https://api.crossref.org/works/10.1056/NEJM198409273111301

Procainamide-induced hemolytic anemia

30 September 2023

13

1 reference

https://api.crossref.org/works/10.1056/NEJM198409273111301

Reticulocytopenic, coombs' positive anemia induced by procainamide

30 September 2023

14

1 reference

https://api.crossref.org/works/10.1056/NEJM198409273111301

Immunomodulatory effect of procainamide in man. Inhibition of human suppressor T-cell activity in vitro

30 September 2023

16

1 reference

https://api.crossref.org/works/10.1056/NEJM198409273111301

Procainamide-lymphocyte reactions. a possible explanation for drug-induced autoimmunity

30 September 2023

17

1 reference

https://api.crossref.org/works/10.1056/NEJM198409273111301

30 September 2023

Identifiers

1 reference

19 October 2017

1 reference